Joanne E Mortimer

Summary

Affiliation: City of Hope National Medical Center
Country: USA

Publications

  1. pmc Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer
    Sumanta K Pal
    Division of Genitourinary Malignancies, Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
    BMC Cancer 12:435. 2012
  2. ncbi request reprint Lessons learned from the bevacizumab experience
    Joanne Mortimer
    Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Cancer Control 19:309-16. 2012
  3. doi request reprint Managing the toxicities of the aromatase inhibitors
    Joanne E Mortimer
    Dept of Medical Oncology and Developmental Therapeutics, Affiliate Programs, City of Hope, Duarte, California 91010, USA
    Curr Opin Obstet Gynecol 22:56-60. 2010
  4. ncbi request reprint Safety considerations for use of bone-targeted agents in patients with cancer
    Joanne E Mortimer
    City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Semin Oncol 37:S66-72. 2010
  5. ncbi request reprint Studying cancer-related fatigue: report of the NCCN scientific research committee
    Joanne E Mortimer
    City of Hope Comprehensive Cancer Center, Los Angeles, California, USA
    J Natl Compr Canc Netw 8:1331-9. 2010
  6. ncbi request reprint Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast cancer
    Sarah Waliany
    Department of Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, USA
    Support Care Cancer 22:2329-36. 2014
  7. pmc Cognitive changes associated with endocrine therapy for breast cancer
    Kunal Agrawal
    Division of Genitourinary Malignancies, Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Maturitas 67:209-14. 2010
  8. pmc Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET
    Joanne E Mortimer
    Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California
    J Nucl Med 55:23-9. 2014

Detail Information

Publications8

  1. pmc Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer
    Sumanta K Pal
    Division of Genitourinary Malignancies, Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
    BMC Cancer 12:435. 2012
    ..In the setting of de novo MBC, large registry analyses cite positive temporal trends in survival, but the extent to which advances in systemic therapy have contributed to these gains is not clear...
  2. ncbi request reprint Lessons learned from the bevacizumab experience
    Joanne Mortimer
    Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Cancer Control 19:309-16. 2012
    ..It has been approved in the management of metastatic colorectal cancer, non-small cell lung cancer, renal cancers, and recurrent glioblastoma multiforme...
  3. doi request reprint Managing the toxicities of the aromatase inhibitors
    Joanne E Mortimer
    Dept of Medical Oncology and Developmental Therapeutics, Affiliate Programs, City of Hope, Duarte, California 91010, USA
    Curr Opin Obstet Gynecol 22:56-60. 2010
    ..Because noncompliance is highest among those who experience side effects, it is important that these symptoms be palliated...
  4. ncbi request reprint Safety considerations for use of bone-targeted agents in patients with cancer
    Joanne E Mortimer
    City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Semin Oncol 37:S66-72. 2010
    ....
  5. ncbi request reprint Studying cancer-related fatigue: report of the NCCN scientific research committee
    Joanne E Mortimer
    City of Hope Comprehensive Cancer Center, Los Angeles, California, USA
    J Natl Compr Canc Netw 8:1331-9. 2010
    ..The committee noted a strong interaction among fatigue, pain, difficulty sleeping, and distress and recommended that future clinical research address these interactions...
  6. ncbi request reprint Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast cancer
    Sarah Waliany
    Department of Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, USA
    Support Care Cancer 22:2329-36. 2014
    ..The purpose of this study is to validate the Bodybugg (BB), a caloric expenditure measuring device, in breast cancer patients undergoing adjuvant and neoadjuvant chemotherapy for early-stage breast cancer...
  7. pmc Cognitive changes associated with endocrine therapy for breast cancer
    Kunal Agrawal
    Division of Genitourinary Malignancies, Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA
    Maturitas 67:209-14. 2010
    ..These and other studies are examined herein to provide a comprehensive overview of the effect of endocrine therapy on cognition...
  8. pmc Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET
    Joanne E Mortimer
    Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California
    J Nucl Med 55:23-9. 2014
    ..The purpose of this study was to evaluate PET/CT of (64)Cu-DOTA-trastuzumab for detecting and measuring tumor uptake of trastuzumab in patients with HER2-positive metastatic breast cancer...